findmyKOL

Dat DO, MD

Basic profile

Interventional Cardiology

ORCIDNone on fileNPI↗
✓ Full record
RegionModesto, CA · WestSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Dat DO is a Cardiology physician. OpenAlex indexes 26 publications with 5,270 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
26publications

Distinct works indexed by OpenAlex.

5,270citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
31companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1540 Florida Ave Ste 100
Modesto, CA 953504430

Telephone

209-577-5557

Provider last certified this registry record 15 Jan 2021.

View the NPPES registry record

Industry payments

31 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    66.2%
    Beta blocker14.9%
    Metoprolol Tartrate37%Carvedilol31%Metoprolol Succinate21%Sotalol9%Atenolol2%Nebivolol Hcl1%
    Part D<11 patients
    Statin13.6%
    Atorvastatin Calcium82%Rosuvastatin Calcium11%Simvastatin5%Pravastatin Sodium2%
    Part D<11 patients

    + 17 more classes in this area

  • Blood & clotting

    16.8%
    Factor Xa inhibitor8%
    Eliquis70%Xarelto30%
    Part D≥108 patients
    P2Y12 inhibitor5.5%
    Clopidogrel62%Brilinta35%Prasugrel Hcl3%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    9%
    Potassium supplement3.8%
    Potassium Chloride100%
    Part D≥82 patients
    SGLT2 inhibitor1.8%
    Jardiance72%Farxiga28%
    Part D<11 patients

    + 6 more classes in this area

Where care is delivered (Part B)98.6% facility · 1.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”